Lung Cancer News,Treatment Articles | Lung Cancer Types & Symptoms

Lung Cancer

LUNG CANCER

FEATURED


LATEST FEATURES

All features >>


LATEST NEWS

lung cancer chest illustration

Atezolizumab Monotherapy Under Review for First-Line Advanced NSCLC Treatment

The FDA has accepted for Priority Review the supplemental Biologics License Application (sBLA) for atezolizumab (Tecentriq®; Genentech) as a first-line monotherapy in patients with advanced non-squamous and squamous non-small cell lung cancer (NSCLC) without EGFR or ALK mutations with high PD-L1 expression (TC3/IC3 wild-type [WT]), as determined by PD-L1 biomarker testing.
Next post in Lung Cancer